Nvest Wealth Strategies’s Novavax NVAX Stock Holding History

Nvest Wealth Strategies’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$547	Hold	58	–	–	﹤0.01%	269
2026 Q1	$473	Hold	58	–	–	﹤0.01%	294
2025 Q4	$390	Buy	+58	New	+$437	﹤0.01%	206

Other funds holding NVAX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

TCMG

TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Oppenheimer & Co New York $9.37B AUM 36.4% 1-Year Est. Return

Nvest Wealth Strategies's NVAX Position: Q2 2026 in Review

Nvest Wealth Strategies held its Novavax (NVAX) position steady in Q2 2026 at 58 shares worth $547. The position accounts for ﹤0.01% of the portfolio, ranked #269.

Nvest Wealth Strategies first reported a position in NVAX in Q4 2025 and has held it in 3 quarters since. 104 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

Nvest Wealth Strategies held 58 shares of Novavax worth $547 as of Q2 2026.
Nvest Wealth Strategies left its Novavax share count unchanged in Q2 2026.
Novavax made up ﹤0.01% of Nvest Wealth Strategies's portfolio in Q2 2026, its #269 holding.
Nvest Wealth Strategies first reported a position in Novavax in Q4 2025 and has held it in 3 quarters since.
104 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Nvest Wealth Strategies's 13F filing for Q2 2026, filed 10 Jul 2026.